{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:35:08Z","timestamp":1767998108485,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.urolonc.2024.11.020","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T12:35:53Z","timestamp":1734093353000},"page":"335.e17-335.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patient preferences for life expectancy cutoffs for aggressive treatment in clinically localized prostate cancer"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0117-7978","authenticated-orcid":false,"given":"John R.","family":"Heard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Luu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Gale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brennan","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-3272","authenticated-orcid":false,"given":"Timothy J.","family":"Daskivich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.11.020_bib0001","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.urology.2016.02.057","article-title":"Questioning the 10-year life expectancy rule for high-grade prostate cancer: comparative effectiveness of aggressive vs nonaggressive treatment of high-grade disease in older men with differing comorbid disease burdens","volume":"93","author":"Daskivich","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2024.11.020_bib0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2296-7-21","article-title":"The single item literacy screener: evaluation of a brief instrument to identify limited reading ability","volume":"7","author":"Morris","year":"2006","journal-title":"BMC Fam Pract"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.020_bib0003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cct.2008.08.002","volume":"30","author":"Wilt","year":"2009","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.020_bib0004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.020_bib0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eururo.2014.12.026","article-title":"Undertreatment of men in their seventies with high-risk nonmetastatic prostate cancer","volume":"68","author":"Bratt","year":"2015","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.11.020_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12214","article-title":"Time trends in use of radical prostatectomy by tumor risk and life expectancy in a National Veterans Affairs cohort","volume":"4","author":"Vaculik","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.020_bib0007","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaoncol.2014.192","article-title":"Population-based assessment of determining treatments for prostate cancer","volume":"1","author":"Chamie","year":"2015","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2024.11.020_bib0008","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jamainternmed.2014.3021","article-title":"Physician variation in management of low-risk prostate cancer: a population-based cohort study","volume":"174","author":"Hoffman","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.020_bib0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1369-7625.2008.00524.x","article-title":"Conceptual problems in laypersons' understanding of individualized cancer risk: a qualitative study","volume":"12","author":"Han","year":"2009","journal-title":"Health Expect"},{"issue":"3","key":"10.1016\/j.urolonc.2024.11.020_bib0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0272989X08327396","article-title":"Laypersons' responses to the communication of uncertainty regarding cancer risk estimates","volume":"29","author":"Han","year":"2009","journal-title":"Med Decis Making"},{"issue":"5","key":"10.1016\/j.urolonc.2024.11.020_bib0011","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.urpr.2015.10.006","article-title":"AUA white paper on implementation of shared decision making into urological practice","volume":"3","author":"Makarov","year":"2006","journal-title":"Urol Pract"},{"issue":"5","key":"10.1016\/j.urolonc.2024.11.020_bib0012","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"N Engl J Med"},{"issue":"45","key":"10.1016\/j.urolonc.2024.11.020_bib0013","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/jncimonographs\/lgs025","article-title":"Results from the Scandinavian Prostate Cancer Group Trial Number 4: a randomized controlled trial of radical prostatectomy versus watchful waiting","volume":"2012","author":"Holmberg","year":"2012","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"4","key":"10.1016\/j.urolonc.2024.11.020_bib0014","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2217\/cer.13.34","article-title":"Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study","volume":"2","author":"Barocas","year":"2013","journal-title":"J Comp Eff Res"},{"issue":"12","key":"10.1016\/j.urolonc.2024.11.020_bib0015","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2024.11.020_bib0016","unstructured":"Cancer of the prostate - Cancer stat facts. SEER. 2023, https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html. Accessed March 3, 2024."},{"key":"10.1016\/j.urolonc.2024.11.020_bib0017","unstructured":"Cint. Accessed November 11 2024, https:\/\/www.cint.com\/"},{"issue":"3","key":"10.1016\/j.urolonc.2024.11.020_bib0018","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/JU.0000000000000287","article-title":"External validation of the prostate cancer specific comorbidity Index: A claims based tool for the prediction of life expectancy in men with prostate cancer","volume":"202","author":"Daskivich","year":"2019","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.11.020_bib0019","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/pcan.2010.33","article-title":"From bad to worse: comorbidity severity and quality of life after treatment for early-stage prostate cancer","volume":"13","author":"Daskivich","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.urolonc.2024.11.020_bib0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.eururo.2012.04.024","article-title":"Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial","volume":"62","author":"Vickers","year":"2012","journal-title":"Eur Urol"},{"issue":"16","key":"10.1016\/j.urolonc.2024.11.020_bib0021","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/cncr.28757","article-title":"Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis","volume":"120","author":"Daskivich","year":"2014","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2024.11.020_bib0022","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.eururo.2018.09.050","article-title":"askMUSIC: leveraging a clinical registry to develop a new machine learning model to inform patients of prostate cancer treatments chosen by similar men","volume":"75","author":"Auffenberg","year":"2019","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.11.020_bib0023","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/0272989X241228612","article-title":"Use of persuasive language in communication of risk during prostate cancer treatment consultations","volume":"44","author":"Naser-Tavakolian","year":"2024","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.urolonc.2024.11.020_bib0024","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/JU.0000000000002675","article-title":"Variation in communication of competing risks of mortality in prostate cancer treatment consultations","volume":"208","author":"Daskivich","year":"2022","journal-title":"J Urol"},{"issue":"21","key":"10.1016\/j.urolonc.2024.11.020_bib0025","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.299.21.2533","article-title":"Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure","volume":"299","author":"Allen","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.urolonc.2024.11.020_bib0026","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamasurg.2021.5803","article-title":"Patient preferences for communication of life expectancy in prostate cancer treatment consultations","volume":"157","author":"Daskivich","year":"2022","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.urolonc.2024.11.020_bib0027","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.juro.2018.06.008","article-title":"Ethical pitfalls when estimating life expectancy for patients with prostate cancer","volume":"200","author":"Leppert","year":"2018","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.11.020_bib0028","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","article-title":"Conjoint analysis applications in health\u2013a checklist: a report of the ISPOR good research practices for conjoint analysis task force","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.urolonc.2024.11.020_bib0029","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/nau.24730","article-title":"Using conjoint analysis to measure the importance of psychosocial traits in the choices of bladder management after spinal cord injury","volume":"40","author":"Welk","year":"2021","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"10.1016\/j.urolonc.2024.11.020_bib0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/0272989X19873667","article-title":"Comparison of rating scale, time tradeoff, and conjoint analysis methods for assessment of preferences in prostate cancer","volume":"39","author":"Kaplan","year":"2019","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.urolonc.2024.11.020_bib0031","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/JU.0000000000002233","article-title":"Ranking important factors for using postoperative chemotherapy in nonmuscle invasive bladder cancer: conjoint analysis results from the Michigan Urological Surgery Improvement Collaborative (MUSIC)","volume":"207","author":"Cary","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.11.020_bib0032","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.urology.2016.07.053","article-title":"Patient-centered treatment decisions for urethral stricture: conjoint analysis improves surgical decision-making","volume":"99","author":"Hampson","year":"2017","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.urolonc.2024.11.020_bib0033","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1089\/end.2020.0370","article-title":"Evaluation of patient treatment preferences for 15 to 20 mm kidney stones: a conjoint analysis","volume":"35","author":"Spradling","year":"2021","journal-title":"J Endourol"},{"key":"10.1016\/j.urolonc.2024.11.020_bib0034","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.urology.2022.01.012","article-title":"Evaluating patient preferences in benign prostatic hyperplasia treatment using conjoint analysis","volume":"164","author":"Huffman","year":"2022","journal-title":"Urology"},{"issue":"15","key":"10.1016\/j.urolonc.2024.11.020_bib0035","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1002\/cncr.26713","article-title":"How does health literacy affect quality of life among men with newly diagnosed clinically localized prostate cancer?","volume":"118","author":"Song","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2024.11.020_bib0036","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.33239","article-title":"Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States","volume":"127","author":"Nguyen","year":"2021","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2024.11.020_bib0037","doi-asserted-by":"crossref","first-page":"682.e11","DOI":"10.1016\/j.urolonc.2020.04.007","article-title":"Examining the association of health literacy and numeracy with prostate-related knowledge and prostate cancer treatment regret","volume":"38","author":"Joyce","year":"2020","journal-title":"Urol Oncol: Semin Org Invest"},{"key":"10.1016\/j.urolonc.2024.11.020_bib0038","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.urology.2021.05.100","article-title":"The role of health literacy in prostate cancer screening","volume":"163","author":"Jamieson","year":"2022","journal-title":"Urology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924007725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924007725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T16:02:44Z","timestamp":1746892964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924007725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1078143924007725"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.11.020","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient preferences for life expectancy cutoffs for aggressive treatment in clinically localized prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}